The Effect of The Walking Exercise Training Given According to Transtheoretical Model, and Follow-Up on Improving Exercise Behavior and Metabolic Control in Type 2 Diabetic Patients
24 de abril de 2018 atualizado por: Emine KAPLAN SERIN, Emine Kaplan Serin
OBJECTIVE This study aims to find out the effects of walking exercise training, which is given according to Transtheoretical Model (TTM), and follow-up on improving exercise behavior and metabolic control in type 2 diabetic patients.
RESEARCH DESIGN AND METHODS The study was conducted as a pre-test, post-test experimental model with 76 intervention (INT) groups and 76 control (CON) groups adult type 2 diabetic patients providing the criteria of the study and followed-up by the diabetes polyclinic of Adıyaman Education and Research Hospital. Patient introduction form (PIF), TTM scales and pedometer were used to collect the data. TTM based training was given to the intervention group according to the patients' change stages at hospital 10 weeks once per every 2 weeks. PIF, TTM scales were applied after the training. PIF, TTM scales were applied to the groups 9 months after the pre-test again.
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Tipo de estudo
Intervencional
Inscrição (Real)
152
Estágio
- Não aplicável
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
18 anos a 65 anos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- Patients who were diagnosed with type-2 diabetes at least six months before, received basic diabetes information, received insulin and/or oral antidiabetic treatment, whose arterial blood pressure was in systolic ≤ 160 mmHg and diastolic ≤ 100 mmHg, who had HbA1c 7% and over, who were literate and had no communication problems were included in the study.
Exclusion Criteria:
- Those who had developed diabetes-related complications (advanced), were pregnant, diagnosed with cancer, had physical and mental problems that prevent walking were excluded from the study.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Quadruplicar
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Intervenção
|
Outros nomes:
|
|
Sem intervenção: Ao controle
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Patient Presentation Form
Prazo: baseline collected
|
The patient presentation form includes questions that question the sociodemographic characteristics and habits of patients, their knowledge of diabetes and its treatment, their exercise status
|
baseline collected
|
|
questions that evaluate the metabolic control variables.
Prazo: Change from Baseline at 9 months
|
FBS, SBS, total cholesterol, HbA1c, LDL, triglyceride, diastolic and systolic BP
|
Change from Baseline at 9 months
|
|
Stages of Change for Exercise Questionnaire
Prazo: Change from Baseline at 9 months
|
It was developed by Prochaska and DiClemente, adapted by Marcus et al. to exercise.
It was adapted to Turkish society by Ay and Temel in 2007.
The scale consists of five questions and reveals the stage of change where the individual in (pre-thinking, thinking, preparation, taking action and maintenance).
|
Change from Baseline at 9 months
|
|
Exercise Processes of Change Scale
Prazo: Change from Baseline at 9 months
|
It was developed by Marcus et al. and adapted to Turkish society by Ay and Temel.
Exercise Processes of Change Scale is based on a 5-point Likert type and consists of 28 items.
The maximum score that an individual can get on the scale is 140, the minimum score is 28.
The scale consists of 10 sub-dimensions and 2 main processes (behavioral process and cognitive process) facilitating change involving these sub-dimensions.
Cognitive processes are increased awareness, dramatic help, environmental reassessment, self-reassessment, social independence.
Behavioral processes are opposition, helping relationships, empowerment management, self-emancipation and stimulus control.
The higher scale scores indicate the higher chance of success of the change.
|
Change from Baseline at 9 months
|
|
Exercise Self-Efficacy Scale
Prazo: Change from Baseline at 9 months
|
It was developed by Marcus et al. and adapted to Turkish society by Ay and Temel.
The scale consists of six items, in the form of five-point Likert.
The maximum score that can be taken from the scale is 30 and the minimum score is 6.
In the general evaluation of the scale, according to the general average composed of item score averages, the self-efficacy of high-value-average subjects is high, and the self-efficacy of subjects below the average is considered to be low.
|
Change from Baseline at 9 months
|
|
Exercise Decisional Balance Scale
Prazo: Change from Baseline at 9 months
|
It was developed by Marcus et al. and adapted to Turkish society by Ay and Temel.
There are two sub-dimensions that assess subjective perception including perceived benefits of exercise practice and perceived harmfulness of exercise.
The scale is based on 5 point Likert type and consists of 10 items.
The overall score of the scale is formed by subtracting the total score of the perceived harmfulness from the total score of the perceived benefit of the exercise practice.
The maximum score can be taken from the scale is 20 and the minimum score is -20.
The negative result indicates that in the exercise decisional balance, the perceived harmfulness is dominant and the positive result indicates that the perceived benefit of exercise practice is dominant on the scale.
|
Change from Baseline at 9 months
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
25 de outubro de 2015
Conclusão Primária (Real)
30 de novembro de 2016
Conclusão do estudo (Real)
30 de novembro de 2016
Datas de inscrição no estudo
Enviado pela primeira vez
9 de abril de 2018
Enviado pela primeira vez que atendeu aos critérios de CQ
24 de abril de 2018
Primeira postagem (Real)
7 de maio de 2018
Atualizações de registro de estudo
Última Atualização Postada (Real)
7 de maio de 2018
Última atualização enviada que atendeu aos critérios de controle de qualidade
24 de abril de 2018
Última verificação
1 de abril de 2018
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- MunzurU
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .